期刊文献+

前列腺癌病理特征与肿瘤组织中MACC1、c-Met、Apaf-1和Caspase-9表达的关系 被引量:3

Relationship between pathological characteristics of prostate cancer and MACC1,c-Met,Apaf-1 as well as Caspase-9 expression in tumor tissue
下载PDF
导出
摘要 目的:研究前列腺癌组织中前列腺癌转移相关基因1(MACC1)、c-Met、凋亡蛋白酶活化因子-1(Apaf-1)和细胞凋亡蛋白酶-9(Caspase-9)的表达及其与肿瘤病理特征的关系。方法:选择2015年5月~2016年3月在我院接受手术治疗的前列腺癌和良性前列腺增生患者作为研究对象,收集术中切除的前列腺癌组织和良性前列腺增生组织并测定MACC1、c-Met、Apaf-1、Caspase-9的表达量,收集血清标本并测定miR-let7i、-32、-128、-196a、-218的表达量。结果:前列腺癌组织中MACC1、c-Met的mRNA含量显著高于良性前列腺增生组织(P〈0.05),Apaf-1和Caspase-9的mRNA含量显著低于良性前列腺增生组织(P〈0.05),且Gleason分级越高、Whitmore-Prout分期越高,前列腺癌组织中MACC1、c-Met的mRNA含量越高(P〈0.05),Apaf-1和Caspase-9的mRNA含量越低(P〈0.05);前列腺癌患者血清中miR-32、miR-128、miR-196a的表达量显著高于良性前列腺增生患者(P〈0.05),且与Apaf-1、Caspase-9的mRNA含量呈负相关,miR-let7i、miR-218的表达量显著低于良性前列腺增生患者(P〈0.05),且与MACC1、c-Met呈负相关。结论:MACC1、c-Met高表达、Apaf-1和Caspase-9的低表达与前列腺癌的发生以及病情发展相关,前列腺癌组织中MACC1、c-Met、Apaf-1、Caspase-9的表达受到miRNAs的调控。 Objective: To study the MACC1,c-Met,Apaf-1 and Caspase-9 expression in prostate cancer tissue and their relationship with the pathological characteristics of tumor. Methods: Prostate cancer and benign prostatic hyperplasia patients who received surgical treatment in our hospital from May 2015 to March 2016 were selected as the research subjects,prostate cancer tissue and benign prostatic hyperplasia tissue were collected during surgery to determine MACC1,c-Met,Apaf-1 and Caspase-9 expression,and serum specimens were collected to determine miR-let7 i,-32,-128,-196 a and-218 expression levels. Results: mRNA content of MACC1 and c-Met in prostate cancer tissue were significantly higher than those in benign prostatic hyperplasia tissue while mRNA content of Apaf-1 and Caspase-9 were significantly lower than those in benign prostatic hyperplasia tissue,and the higher the Gleason grading and the higher the Whitmore-Prout staging,the higher the mRNA content of MACC1 and c-Met in prostate cancer tissue and the lower the mRNA content of Apaf-1 and Caspase-9; serum miR-32,miR-128 and miR-196 a expression levels in prostate cancer patients were significantly higher than those in patients with benign prostatic hyperplasia and negatively correlated with the mRNA content of Apaf-1 and Caspase-9,and the expression levels of miR-let7 i and miR-218 were significantly lower than those in patients with benign prostatic hyperplasia and negatively correlated with MACC1 and c-Met. Conclusions: High MACC1 and c-Met expression and low Caspase-9 and Apaf-1 expression are related to the occurrence and progression of prostate cancer,and the MACC1,c-Met,Apaf-1 and Caspase-9 expression in prostate cancer tissue are regulated by miRNAs.
出处 《海南医学院学报》 CAS 2016年第16期1873-1876,共4页 Journal of Hainan Medical University
基金 云南省科技厅昆明医科大学应用基础研究联合专项课题(H0513)~~
关键词 前列腺癌 增殖 凋亡 microRNA Prostate cancer Proliferation Apoptosis microRNA
  • 相关文献

参考文献15

  • 1Bennett HY,Roberts MJ,Doi SA,et al.The global burden of major infectious complications following prostate biopsy[J].Epidemiol Infect,2015,9:1-8.
  • 2Füeβl HS.Prostate cancer-unexpected prevalence[J].MMW Fortschr Med,2015,157(19):38.
  • 3Nakamura K,Terada N,Kobayashi T,et al.Clinical characteristics of prostate ductal adenocarcinoma in Kyoto University Hospital[J].Hinyokika Kiyo,2015,61(12):487-491.
  • 4Koca O,Un S,Türk H,et al.The factors predicting biochemical recurrence in patients with radical prostatectomy[J].Arch Ital Urol Androl,2016,87(4):270-275.
  • 5Ma J,Ma J,Meng Q,et al.Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma[J].Pathol Oncol Res,2013,19(4):821-832.
  • 6Jung J,Kim HY,Maeng J,et al.Interaction of translationally controlled tumor protein with Apaf-1 is involved in the development of chemoresistance in He La cells[J].BMC Cancer,2014,7(14):165.
  • 7Barzi A,Klein EA,Dorff TB,et al.Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer[J].Prostate Cancer Prostatic Dis,2016,19(1):84-91.
  • 8Zhang R,Shi H,Ren F,et al.Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells[J].Oncol Rep,2016,35(4):2466-2472.
  • 9Koh YW,Hur H,Lee D.Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma[J].Pathol Res Pract,2016,212(2):93-100.
  • 10Dai ZJ,Liu XH,Kang HF,et al.Genetic variation in metastasisassociated in colon cancer-1 and the risk of breast cancer among the Chinese Han Population:A STROBE-Compliant Observational Study[J].Medicine(Baltimore),2016,95(6):e2801.

二级参考文献48

  • 1Siegel R,Ward E,Brawley O,et al.Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J]. CA CancerJ Clin,2011,61(4):212-236. doi: 10.3322/caac.20121.
  • 2Stein U,Dahlmann M,Walther W.MACC1- more than metastasis? Facts and predictions about a novel gene[J]. J Mol Med (Berl),2010, 88(1):11-18. doi: 10.1007/s00109-009-0537-1.
  • 3Stein U,Walther W,Arh F,et al. MACC 1, a newly identified key reg- ulator of HGF-MET signaling, predicts colon cancer metastasis[J]. Nat Med, 2009,15(1): 59-67. doi:10.1038/nm.1889.
  • 4Stein U.MACCI-a novel tatget for solid cancers[J].Expert Opin Ther Targets,2013,17(9):1039-1052. doi: 10.1517/14728222.2013.815727.
  • 5Bottaro DP, Rubin JS, Faletto DL,et al. Identification of the hepato- cyte growth factor as the C-met proto-oncogene product[J].Science, 1991,251 (4995) :802-804. doi: 10.1126/science. 1846706.
  • 6Rosario M, Birchmeier W. How to make tubes: signaling by the Met receptor tyrosine kinase[J]. Trends Cell Biol,2003,13(6):328-335. doi: 10.1016/S0962-8924(03)00104-1.
  • 7Gherardi E, Birchmeier W, Birchmeier C, et al.Targeting MET in cancer: rationale and progress[J]. Nat Rev Cancer,2012,12(2):89- 103. doi: 10.1038/nrc3205.
  • 8Varkaris A, Corn PG, Gaur S, et al. The role of HGF/c-Met signal- ing in prostate cancer progression and c-Met inhibitors in clinical trials[J]. Expert Opin Investig Drugs,2011,20(12):1677-1684. doi: 10.1517/13543784.2011.631523.
  • 9Stein U, Smith J, Walther W, et al. MACC1 controls Met: what a dif- ference an Spl site makes[J].Cell cycle,2009,8(15):2467-2469, doi: 10.4161/ec.8.15.9018.
  • 10Russo AL, Jedlicka K, Wernick M, et al. Urine analysis and protein networking identify met as a marker of metastatic prostate cancer[J]. Clin Cancer Res, 2009, 15(13): 4292-4298. doi:10.1158/1078- 0432.CCR-09-0599.

共引文献14

同被引文献30

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部